General Perception of Liposomes: Formation, Manufacturing and Applications by Nkanga, Christian Isalomboto et al.
Selection of our books indexed in the Book Citation Index 
in Web of Science™ Core Collection (BKCI)
Interested in publishing with us? 
Contact book.department@intechopen.com
Numbers displayed above are based on latest data collected. 
For more information visit www.intechopen.com
Open access books available
Countries delivered to Contributors from top 500 universities
International  authors and editors
Our authors are among the
most cited scientists
Downloads
We are IntechOpen,
the world’s leading publisher of
Open Access books
Built by scientists, for scientists
12.2%
122,000 135M
TOP 1%154
4,800
1Chapter
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Abstract
Liposomes are currently part of the most reputed carriers for various molecular 
species, from small and simple to large and complex molecules. Since their discovery, 
liposomes have been subject to extensive evolution, in terms of composition, manu-
facturing and applications, which led to several openings in both basic and applied life 
sciences. However, most of the advances in liposome research have been more devoted 
to launching new developments than improving the existing technology for potential 
implementation. For instance, the evolution of the conventional lipid hydration meth-
ods to novel microfluidic technologies has permitted upscale production, but with 
increase in manufacturing cost and persistent use of organic solvents. This chapter 
intends to present general concepts in liposome technology, highlighting some long-
standing bottlenecks that remain challenging to the preparation, characterization and 
applications of liposomal systems. This would enhance the understanding of the gaps 
in the field and, hence, provide directions for future research and developments.
Keywords: phospholipids, soybean lecithin, liposome composition, manufacturing 
methods, characterization techniques
1. Introduction
Liposomes are artificial lipid-based bilayered vesicles. They were firstly discov-
ered and described in 1965 by Bangham et al. [1] as swollen phospholipid systems, 
namely Banghasomes. A few years later, the structural description of liposomes was 
unveiled as small devices made of one or more closed phospholipid bilayers. Due to 
the diversity of particle sizes, from 20 nanometers to several micrometers, liposo-
mal vesicles are considered as either nanoparticles or microparticles endowed with 
the ability to encapsulate materials of various nature and polarity [2, 3].
Up until now, liposomes have shown huge promise as potential vehicles for 
biologically active compounds in cosmetic and pharmaceutical industries. These 
applications have been extended to food and farm industries, where unstable 
substances such as antioxidants, flavors and antimicrobials have been explored for 
liposomal encapsulation. Across all these areas of application, liposomes have been 
deemed to be the most successful delivery systems due to their multiple advantages. 
These include high biocompatibility and biodegradability, low toxicity and poor 
immunogenicity, improved drug solubility and controlled distribution, as well as 
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the ability of performing surface modifications for targeted, extended and sus-
tained release. Currently, there are several liposomal formulations that are clinically 
established for the treatment of various diseases, such as cancer, fungal and viral 
infections; and many more have reached advanced phases of clinical trials [4, 5].
Although liposomes have shown some success in drug product development, the limi-
tations identified in liposomal technology have remained almost stagnant over decades. 
The most common disadvantages of liposomes arise partly from poor stability under 
shelf and in vivo conditions. This is mostly due to potential lipids oxidation and hydroly-
sis, leakage and loss of hydrophilic cargoes, as well as particles fission and fusion. To date, 
some of these problems can be circumvented by playing around formulation adjuvants, 
such as anti-oxidants, or post-preparation processing, such as freeze-drying [4, 6, 7].
While describing broadly the current perception of liposomes, regarding 
production, evaluation and applications; this chapter intends to highlight the 
longstanding bottlenecks that remained overlooked and challenging to product 
development and implementation. This would increase the understanding of the 
gaps in the field and provide future directions to new openings for improvements in 
liposome technology.
2. Liposomes formation and classification
2.1 Liposomes formation
The liposomal vesicles derive from hydration of phospholipids, which are 
amphiphilic molecules endowed with a hydrophilic head group and two hydropho-
bic acyl chains (Figure 1). In aqueous media, phospholipid molecules self-assemble 
Figure 2. 
Flowchart illustrating liposome formation and encapsulation of drug molecules.
Figure 1. 
Chemical structure of a representative phospholipid molecule (distearoyl phosphatidylcholine).
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into a bilayered structure. Within the bilayer, phospholipid polar groups line up to 
form a water-attracting surface while their lipophilic chains face each other to yield 
a water-free zone. On mechanical shaking or heating, phospholipid bilayers con-
tinuously enclose the dispersing aqueous medium and form a vesicular system. In 
this system, hydrophilic groups of phospholipids are oriented towards the inner and 
outer aqueous phase, while their hydrophobic tails are centered within the bilayer 
[2, 4]. This architecture underlines the ability of liposomes to readily encapsulate 
hydrophilic and hydrophobic materials inside the inner aqueous core and the lipid 
bilayers, respectively (as illustrated in Figure 2).
2.2 Liposomes classification
Depending on the particle size and number of bilayers forming the vesicles 
(lamellarity), liposomes can be categorized in the following classes [4, 8]:
• Small unilamellar vesicles (SUV), size range 20–100 nm;
• Large unilamellar vesicles (LUV), size >100 nm;
• Giant unilamellar vesicles (GULV), size >1000 nm;
• Oligolamellar vesicles (OLV), size range 100–1000 nm;
Vesicle 
designation
Main components Illustrative application
Emulsomes A mixture of fats and triglycerides 
stabilized by high proportion of 
lecithin
Emulsomes loaded with Amphotericin B for 
the treatment of visceral leishmaniasis [9]
Enzymosomes Complexes of lipids and enzymatic 
proteins
Encapsulation and delivery of superoxide 
dismutase for oxidative stress management [9]
Sphyngosomes Sphingolipids containing amide and 
ether bonds
Sphyngosomes loaded with vincristine 
(Marqibo®) for lymphoblastic leukemia 
therapy [4]
Transfersomes A mixture of single chain surfactant, 
phospholipids and ethanol (10%)
Transfersomes loaded with diclofenac for 
improved topical delivery/retention [10]
Ethosomes Phospholipids and ethanol 
(20–40%)
Mitoxantrone-loaded ethosomes for the 
treatment of melanoma [11]
Pharmacosomes Conjugate of drug and phospholipid Pharmacosomes loaded with diclofenac for 
enhanced the bioavailability and reduced 
toxicity [9]
Virosomes Viral glycoproteins Virosome containing HIV-1 gp41-subunit 
antigens for protection against vaginal 
simian-HIV [12]
Aquasomes Tin oxide, diamonds or brushite core 
covered with oligomeric film
PEG-lipid coated aquasomes containing 
interferon-α-2b for prolonged and enhanced 
cytotoxicity [13]
Bilosomes Bile salts and acids (deoxycholic 
acid)
Bilosomes loaded with diphtheria toxoid for 
systemic and mucosal immunization [14]
Niosomes Non-ionic surfactants (span and 
tween)
Niosomes based formulation for enhanced oral 
bioavailability of candesartan cilexetil [15]
Table 1. 
Presentation of liposome-type systems.
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Figure 3. 
Structural representation of ester glycerol-phospholipid molecules, with R1 and R2 representing the 
hydrocarbon chains of different fatty acids.
• Multilamellar large vesicles (MLV), with size >500 nm;
• Multivesicular vesicles, size from 1000 nm to several thousand nanometers.
Based on their composition, liposomes can be classified as conventional, long 
circulating, cationic, stimuli-responsive and immunoliposomes. The differences 
between these categories will be highlighted later when discussing composition and 
evolution of liposomes.
Furthermore, there are many other vesicular systems considered as part of the 
liposome-type vesicles. These include emulsomes, enzymosomes, sphyngosomes, 
transfersomes, ethosomes, pharmacosomes and virosomes, which are lipid-based 
liposomes analogous. The non-lipid-based liposomes analogous are aquasomes, 
bilosomes and niosomes [8, 9]. All the liposome-type systems are briefly presented 
in Table 1.
3. Liposomes composition and evolution
3.1 Liposomes composition
Liposomes are made of physiologically acceptable natural or synthetic phospho-
lipids found in the lipid bilayer membranes of human cells. The most frequently 
used phospholipids for liposomes preparation are phosphatidylcholines (PC), 
phosphatidylethanolamines (PE), phosphatidylserines (PS) and phosphatidylglyc-
erols (PG) [16]. The molecular structures of these biocompatible lipids are shown 
in Figure 3 and Table 2.
In liposomal technology, a considerable attention is given to the phase transition 
temperature (Tt) of these phospholipids. The Tt corresponds to the temperature 
above which phospholipids exist in liquid crystalline phase. In this fluid state, 
hydrophobic tails of phospholipids are randomly oriented but ready to form closely 
continuous bilayered vesicles (liposomes). Below the Tt, phospholipids exist in gel 
state, where the hydrophobic tails are completely expanded and well packed, thus 
not able to form liposomes [4, 17].
As most of the phospholipids used for liposomes formulation have Tt close to the 
physiological temperature (37°C), the addition of cholesterol has been adopted as a 
strategy to stabilize the liposomal vesicles in physiological media. This is especially 
for phospholipids that can undergo phase transition and leakage at room tempera-
ture, which can lead to premature release of the liposome cargo. In fact, due to its 
high hydrophobicity, cholesterol was found efficient in strengthening the packing 
of phospholipid bilayers, reducing therefore membrane permeability. Numerous 
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studies have reported the ability of cholesterol to impact liposomes properties and 
functionality, including encapsulation efficiency and release characteristics [18–
20]. The work by Kirby et al. [21] demonstrated that increasing cholesterol content 
can prevent leakage and improve in vivo stability of liposome. Later, Lopez-Pinto 
et al. [22] observed a direct correlation between cholesterol content and liposome 
sizes. These observations have established cholesterol content to be a key parameter 
in liposome formulation.
Like cholesterol, there are many other ingredients that can affect liposomes 
behavior and afford the desired encapsulation or delivery profiles. Additive agents 
such as oleic acid and N-[1(2,3-dioleoyloxy) propyl]-N,N,N-trimethylammonium 
chloride (DOTAP) are useful for the preparation of negatively and positively 
charged liposomes, respectively. These charged liposomes offer the advantage of 
great liposomal stability during the storage, as charged particles repel each and 
reduce aggregation tendencies. While the cell internalization of positively charged 
liposomes (cationic liposomes) is promoted by their electrostatic interaction with 
cell membranes (which are negatively charged), liposomes bearing negative charges 
are subjective to poor cell internalization due to the corresponding repulsive forces. 
Cationic liposomes are used in gene therapy due to their ability to successfully 
encapsulate nucleic acids by electrostatic forces [4, 23].
In addition, some special lipids such as cholesteryl hemisuccinate (CHEMS) and 
1,2-dioleoyl-sn-glycero-3-phosphoethanolamine (DOPE), have been widely used to 
prepare liposomes with pH-dependent release features. CHEMS can exhibit pH-sensi-
tivity either alone or in the presence of other lipids. In ionized forms at basic or neutral 
pH, CHEMS stabilizes the lamellar form of DOPE in lipid-based vesicles. However, 
the protonated or molecular CHEMS formed at acidic pH promotes hexagonal phase 
of this lipid, which leads to the disruption of the vesicular systems and release of the 
encapsulated materials [24, 25]. Tocopherol hemisuccinate (THS) has also shown 
similar pH-responsiveness as CHEMS, due to their molecular similarity [26].
The composition of liposome appears to be a broad topic, but also very crucial 
for the desired product development. However, the nature and costs of the liposome 
components used over decades viz., particularly the synthetic or highly puri-
fied natural phospholipids, have been reported to be part of the factors affecting 
negatively the universal implementation and affordability of liposome technology 
[16, 27]. The review by Machado et al. [28] discussed the feasibility of using crude 
soybean and rice lecithin for liposomal encapsulation of food ingredients. The 
authors demonstrated these naturally occurring phospholipid mixtures could be 
useful for liposomes preparation regardless of the intended area of application. Our 
group has recently investigated liposomal encapsulation of isoniazid using crude 
soybean lecithin. The formulated liposomes exhibited much better encapsulation 
efficiency than purified soybean lecithin [29]. This study proposed crude soybean 
lecithin for liposomal encapsulation of drug molecules. However, the complexity 
of this lipid mixture might be a bottleneck for some biomedical applications, where 
molecular architecture of the lipid bilayer is explored to get insights into potential 
Phospholipids PC PE PS PG
Table 2. 
Description of –X moieties of different glycerol-phospholipids [16].
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cell membrane permeability. The versatility of crude soybean lecithin liposomes 
is therefore in question, considering the wide range of areas that the liposomal 
systems usually cover.
3.2 Liposomes evolution
Based on the composition, liposomal systems can be considered to have evolved 
from conventional, long circulating, targeted and immune-liposomes to stimuli-
responsive liposomes. The liposomes composed purely of phospholipids with or 
without cholesterol (conventional liposomes) have shown some limitations due to 
their uptake by the cells of the mononuclear phagocytic system (MNPS), such as 
macrophages that ensure liposomes clearance through phagocytosis. This biological 
fate makes conventional liposomes appropriate vehicles for targeted drug delivery 
to infected MNPS cells, like the case of alveolar macrophages where Mycobacterium 
tuberculosis resides often. However, the uptake by the MNPS cells decreases lipo-
somes half-life and exposes to high risk of therapeutic failure when the site of 
interest is beyond the MNPS [2].
Extensive studies conducted in liposome technology led to identification of 
some astute strategies for addressing the issue of MNPS’ attack viz., liposome 
downsizing and surface modification. In this regard, it was observed that the physi-
ological clearance of larger liposomes (MLV) was much quicker than that of smaller 
liposomes (SUL), which describe long-circulating profiles with increased half-lives 
[30]. The stealth strategy arising from surface modification involved grafting or 
coating hydrophilic polymers such as polyethylene glycol (PEG) and chitosan, 
which prevents detection of liposomes by the MNPS cells. While stealth behavior 
allows liposomes to achieve much longer circulation time (hence the name “long 
circulating liposomes”), this strategy comes along with poor targeting efficiency 
due to wider distribution of liposomes in the body. From this limitation, further 
developments have led to introduction of targeted liposomes. These liposomes are 
characterized by surface decoration with glycoproteins, polysaccharides or specific 
receptors ligands to achieve narrowed distribution and accumulation at the site of 
interest [9, 31]. The observation that ligand-decorated liposomes could provide 
selective drug accumulation inspired further design of antibody-functionalized 
liposomes (immunoliposomes) as well as stimuli-responsive liposomal systems 
for controlled drug delivery [32]. Figure 4 shows the trend in the development of 
“intelligent” liposomes for site-specific delivery; from conventional liposomes, 
stealth liposome, targeted liposomes, immunoliposomes to stimuli-responsive 
liposomes.
Stimuli-responsive liposomes are smart liposomal systems that exhibit rapid 
release of the cargo upon changes in some physicochemical or biochemical stimuli, 
such as pH, temperature, redox potentials, enzymes concentrations, ultrasound, 
electric or magnetic fields [33, 34]. Among these stimuli, pH change is the most 
promising stimulus due to the existence of multiple pH gradients in the body [35]. 
In common practice, formulation of pH-sensitive liposomes involves incorporation 
of CHEMS and DOPE. Although CHEMS-DOPE-based liposomes have shown great 
promise for controlled delivery [24, 25, 36], the costly status of these lipids remains 
a deep concern for wider development and application of liposome products. To 
circumvent the use of such special lipids for pH-dependent delivery, our group has 
considered hydrazone derivatization of isoniazid (INH), as a small hydrophilic drug 
model, followed by encapsulation using crude soybean lecithin for cost-effective 
development [37]. Being poorly water soluble, the prepared conjugates were suc-
cessfully embedded within the lipid membranes and INH release experiments were 
conducted in different pH media. The INH-conjugate loaded crude soybean lecithin 
7General Perception of Liposomes: Formation, Manufacturing and Applications
DOI: http://dx.doi.org/10.5772/intechopen.84255
liposomes have demonstrated attractive nanoparticulate and stimuli-responsive 
characteristics for potential low-cost site-specific liposomal delivery [38]. However, 
the amounts of INH-derivatives loaded were found to be almost 10-folds lesser than 
the loading achieved when native INH was encapsulated in crude soybean lecithin 
liposomes, which was in turn associated with some burst release [29]. This is prob-
ably due to the fact that INH derivatives are encapsulated in the lipid bilayer, which 
offers limited space for loading [39], while the native INH was trapped within the 
aqueous core of liposomes. These limitations underline the need for further devel-
opments in liposome technology to achieve controlled release from cost-effective 
liposomes, combining both use of cheap lipids and high drug loadings.
4. Liposomes preparation and characterization
4.1 Preparation methods
Liposomes can be prepared using a wide range of methods that involve combina-
tion of lipids with aqueous media, and somehow affect liposomes characteristics, 
such as size, lamellarity and encapsulation efficiency (EE). The recently reported 
methods can be categorized as conventional, which mostly involve approaches that 
are easy to use at laboratory scale, and novel methods that appear to be more useful 
for up-scale production but require some special equipment [4].
4.1.1 Conventional methods
The most commonly used methods for formulation of liposomes share the fol-
lowing fundamental stages: (i) lipids dissolution in organic solvents, (ii) drying of 
the resultant solution, (iii) hydration of dried lipid (using various aqueous media), 
(iv) isolation of the liposomal vesicles, and (v) quality control assays [6]. While 
sharing these basic stages, the conventional preparation methods gather different 
advantages and disadvantages that are comparatively presented in Table 3.  
The specific technological details of these methods are separately discussed in the 
following paragraphs.
Figure 4. 
Schematic representation of the trend in liposome improvements for site specific delivery. (A) Conventional liposomes, 
(B) stealth liposome, (C) targeted liposomes, (D) immunoliposomes and (E) stimuli-responsive liposomes [32].
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4.1.1.1 Film hydration
Also known Bangham method, film hydration represents the simplest and oldest 
method used in liposome technology. In this method, lipids are firstly dissolved in 
a suitable organic solvent, and dried down to yield a thin film at the bottom of the 
flask. The obtained lipid film is hydrated using an appropriate aqueous medium to 
produce liposomal dispersion. The structural organization of the formed vesicles 
can be affected by the hydration conditions. A gentle hydration of the lipid film 
forms giant unilamellar vesicles (GULV), whereas a hash hydration gives rise to 
multilamellar vesicles (MLV) with poor size homogeneity, which requires an addi-
tional downsizing step. The most commonly used sizing methods include probe and 
bath sonication that afford production of small unilamellar vesicles (SUV). Despite 
its higher effectiveness, probe sonication is often blamed for potential contamina-
tion (with titanium from the titanium-based nozzle used for mechanical agitation), 
and production of local heat that can affect lipids and drugs stability. Although the 
two sonication methods produce liposomes with identical characteristics, the use of 
bath sonication remains a better option due to easy control of operational param-
eters. Another technique used for liposome sizing includes consecutive extrusion 
of the liposomal formulation through polycarbonate filters of defined pore sizes. 
In this method, the number of extrusion cycles is the key parameter to control for 
effective homogenization [4, 6].
4.1.1.2 Reverse phase evaporation
Reverse phase evaporation is an alternative method to the film hydration that 
involves formation of water-in-oil emulsion between the aqueous phase (containing 
hydrophilic materials) and the organic phase (containing lipids and any hydropho-
bic materials). A brief sonication of this mixture is required for system homogeni-
zation. The removal of the organic phase under reduced pressure yields a milky gel 
Method 
designation
Advantages Disadvantages
Film hydration 
(Bangham 
method)
Straightforward process Use of organic solvent and mechanical agitation, 
production of large particles with no control 
on size, poor encapsulation efficiencies of 
hydrophilic materials, time consuming, 
sterilization issue
Reverse phase 
evaporation
Simple design, suitable 
encapsulation efficiency
Not applicable to fragile cargoes, use of large 
quantity of organic solvent, time consuming, 
sterilization issue
Solvent injection Straightforward approach Trace of organic solvent as residue, possible 
nozzle blockage in ether system, time consuming, 
sterilization issue
Detergent 
removal
Simple design, homogenous 
product, control of particle size
Presence of organic solvent, detergent residue, 
time consuming, low entrapment efficiency, poor 
yield, sterilization required
Heating method Simple and fast process, 
organic solvent free, no need 
for sterilization, possible 
up-scale production
The need for high temperature
Adapted from [40].
Table 3. 
Advantages and disadvantages of conventional methods.
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that turns subsequently into liposomal suspension. The liposomes can be isolated 
from the dispersion using centrifugation, dialysis or sepharose 24 column [28].
4.1.1.3 Solvent injection
Solvent injection involves quick injection of the lipid solution (in ethanol or 
diethyl ether) into an aqueous medium. The experiment is performed either at room 
or at higher temperature (e.g., 60°C), depending on whether the organic solvent 
is water-miscible or not. The liposomes prepared by solvent injection process are 
mostly polydispersed and highly contaminated by organic solvents, especially 
ethanol due to formation of azeotrope mixture with water. As presented in Table 3, 
solvent injection suffers from several drawbacks including continuous exposure of 
the therapeutic agents to high temperature and organic solvent that might affect both 
the stability and safety of the liposomal products [28, 40].
4.1.1.4 Detergent removal
In the detergent removal method, phospholipids are dissolved in aqueous 
solution containing detergents at critical micelle concentrations (CMC). Upon 
detergent removal, the reaction medium frees individual phospholipid molecules 
that self-assemble into bilayered structures. Detergent removal is mostly achieved 
by means of a dialysis bag, polystyrene-based absorber beads or Sephadex columns 
(gel permeation chromatography). Dilution of the resultant mixture with some 
appropriate aqueous medium leads to restructuration of the formed micelles that 
evolve to liposomes [4, 6].
4.1.1.5 Heating method
Among all the conventional methods, the heating method is known to be the 
most attractive method for liposomes preparation due to its organic solvent free 
characteristics. In the heating method, lipids are hydrated for 1 hour, and heated for 
another hour above the transition temperature of the phospholipids in the presence 
of a hydrating agent (glycerin or propylene glycol 3%). When cholesterol is part 
of the formulation, the reaction medium is heated up to 100°C because of its high 
melting point. Being prepared under heating conditions, the resultant liposomes 
can be readily used without any further sterilization treatments, which minimizes 
both formulation complexity and timing. In addition, there is no need for further 
removal of the hydrating agents employed, since these represent physiologically 
acceptable ingredients that are well-established for pharmaceutical applica-
tions. Moreover, the observation that these hydrating agents can prevent particle 
coagulation and sedimentation makes them much more attractive as stabilizer 
and isotonizing additives. The hydroxyl groups of these hydrating agents provide 
a cryoprotective effect that makes the heating method an efficient method for the 
formulation of inhalable liposomes [41, 42].
4.1.2 Novel preparation methods
4.1.2.1 Microfluidic channel method
Microfluidic methods include all the novel techniques that make use of micro-
scopic channels (in the size range of 5–500 μm). In this method, lipids are dissolved 
in an appropriate organic solvent (ethanol or isopropanol) and the resultant 
solution is propelled perpendicularly or in the opposite direction to the aqueous 
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medium within the micro-channels. The continuous axial mixing of the organic 
and aqueous solutions leads to liposomes formation because of local diffusion 
of phospholipids in aqueous phase, which encourages the self-assembly process. 
Among many others, the micro hydrodynamic focusing method represents the 
most commonly used microfluidic method for liposomes formulation. This method 
produces small and large unilamellar vesicles, 40–140 nm, with good size homo-
geneity (mono dispersed feature). The other microfluidic techniques include the 
microfluidic droplets and the pulsed jet flow microfluidic methods. The microflu-
idic droplets method involves dissolution of phospholipids in hexane for prepara-
tion of giant liposomes (4–20 μm). In the pulsed jet flow microfluidic method, the 
conventional film hydration method has been modified by drying the lipid solution 
in microtubes. The resultant lipid film is hydrated within the microtubes through a 
perfusion process that produces much larger vesicles, 200–534 μm, with remarkable 
encapsulation efficiency [4, 43]. As common advantages, the microfluidic methods 
offer the possibility for production of vesicles with desired size, due to the versatil-
ity and flexibility of the methods. The disadvantages of these methods include the 
imperative use of organic solvent and drastic agitation, as well as difficulty for large 
scale production [40].
4.1.2.2 Supercritical fluidic method
While being considered as equivalent to the conventional reverse phase evapora-
tion method, supercritical fluidic technique represents the most important novel 
liposome preparation methods that makes use of a supercritical fluid, such as 
carbon dioxide (CO2) maintained under supercritical conditions (supercritical 
temperature and pressure). In this state, CO2 is an excellent solvent for the lipids. 
The high-performance liquid chromatography (HPLC) pump provides a continu-
ous flow of the aqueous phase into a view cell that contains the supercritical lipid 
solution, allowing phase transition of the dissolved phospholipids. Upon sudden 
decrease in pressure, CO2 gets completely removed and phospholipids self-assemble 
into a bilayered vesicular system. The supercritical fluidic method affords large 
unilamellar vesicles (100–1200 nm) with 5-fold higher encapsulation efficiency 
than the equivalent conventional method. Apart from being organic solvent-free 
methods, the supercritical fluidic method offers many other advantages such as 
the use of CO2, as a cheap and environmentally harmless solvent, possibility for 
controlling particle size, in situ sterilization and large-scale production in industrial 
settings. However, the disadvantages of the supercritical fluidic technique, includ-
ing particularly its high cost, low yield and use of high pressures (200–350 bar) 
which require special infrastructures, restrict their universal applications for wider 
developments of liposomal technology [4, 40, 43].
4.1.3 Post-preparation treatments
4.1.3.1 Freeze-thawing
The freeze-thawing treatment involves freezing the liposomes dispersion in 
liquid nitrogen, and subsequently thawing it at the temperature above the phase 
transition temperature of the lipids used for formulation. Upon freeze-thawing, the 
liposomal vesicles are subjected to fusion since the lipid bilayers become fluid and 
highly permeable, allowing extensive diffusion of hydrophilic molecules, which 
leads to important cryoconcentration. These structural modifications encourage 
encapsulation of hydrophilic materials that are poorly loaded in liposomes when 
conventional methods are used. This underlines the reason why freeze-thawing 
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represents an important treatment in liposome technology. Amongst the key 
parameters to be considered for freeze-thawing optimization are the number and 
duration of freeze-thawing cycles. These can impact significantly not only the 
encapsulation efficiency but also structural characteristics, i.e., liposomes lamellar-
ity and polydispersity [44, 45].
4.1.3.2 Freeze-drying
Commonly known as lyophilization, freeze-drying is a post-preparation treat-
ment for liposomes that is applied in both laboratory and industrial settings to pre-
serve the characteristics of liposomal products. Freeze-drying involves freezing of 
the aqueous samples and subsequent removal of ice by sublimation. Freeze-drying 
represents a very useful treatment for shelf stability of liposomal suspensions, since 
water molecules can trigger some chemical reactions and lead to modification of 
the cargo or excipients in the formulation. Freeze-drying appears to be of great 
interest when the prepared formulation contains thermos-sensitive materials such 
as proteins, nucleic acids, etc., which might undergo fast degradation when sub-
jected to heat-drying. The use of freeze-drying has gained considerable attention 
in liposome technology due to improved storage stability of liposomal products. 
Because of potential leakage of liposomes during freeze-drying, addition of hydro-
philic compounds, commonly called cryoprotective agents (such as carbohydrates), 
has been established to ensure good stability and quality of the final product. The 
cryoprotectants commonly used include mannitol, lactose, sucrose and trehalose. 
Among these, trehalose is the most reputed cryoprotecting agent since it preserves 
liposomes stability during and after freeze-drying treatment [6].
4.2 Characterization techniques
After production, liposome formulations are subjected to extensive charac-
terization, evaluating the physicochemical properties of liposomes that affect 
their shelf stability and biological performance. The most routinely investigated 
parameters in liposome characterization include vesicle size and size distribution 
(or polydispersity), surface charge (or Zeta potential), shape and morphology, 
lamellarity, encapsulation efficiency, phase behavior (or polymorphism) and 
in vitro release profile [4, 46]. Table 4 indicates the techniques used for evaluation 
of liposome characteristics. The most frequently used methods are briefly discussed 
in the following paragraphs.
4.2.1 Dynamic light scattering (DLS)
Also known as photon correlation spectroscopy or quasi-elastic light scattering, 
DLS represents the most commonly used method for determination of liposome 
size, size distribution (polydispersity) and Zeta potential (surface charge). DLS is 
done by an instrumental setting called Zetasizer Nano. The standard operational 
principle of DLS is based on continuous motion of dispersed particles due to their 
bombardment by solvent molecules (Brownian motion). This phenomenon causes 
remarkable scattering of the applied light. Since the extent of fluctuation in light 
intensity is associated with the diffusion rate of the suspended particles, which 
is related to particle diameter (smaller particles diffusing faster than the larger 
ones), the particle size is automatically deducted from the estimated amount of the 
scattered light. When addressing Zeta potential measurements, DLS allows surface 
charge determination by accessing changes in the scattered light intensity caused 
by particle motion due to the electric field applied. In other words, for surface 
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charge (Zeta potential) evaluation, changes in the intensity of the scattered light are 
governed by the applied electric field (which causes extensive motion of charged 
particles), in contrast to size measurements where Brownian motion is the key fac-
tor [4, 47]. Apart from being a simple, fast and reliable method for routine analyses, 
DLS offers many other advantages including the fact that the measurement is taken 
from a native environment, and a wide size range can be evaluated (from a few 
nanometers to several micrometers). However, DLS shows some limitations such 
as the difficulty of differentiating individual particles from aggregates and high 
sensitivity to contaminants [48]. In addition, DLS is technically unable to provide 
true particle size, but rather hydrodynamic diameter due to particle solvation. 
Water layers on particle surface lead to false readings of particle diameters in aque-
ous media [49].
4.2.2 Transmission electron microscopy (TEM)
The microscopic observation provides direct visualization of the liposomal ves-
icles as individual particles, which allows effective analysis of shape and morphol-
ogy as well as a precise and reliable size reading. In this context, TEM techniques 
are commonly used in liposome technology for structural characterizations. In 
TEM experiments, the liquid sample is spotted onto a copper grid, and the solvent 
dried prior to the microscopic analysis. Under TEM instrument, liposomal vesicles 
mostly appear as black spherical particles on a white background. For a variant 
TEM technique like negative staining TEM, liposomes appear as bright spherical 
spots on a black background since the spotted sample is treated with uranyl acetate 
or phosphotungstic acid (as negative staining agent). Due to its effectiveness, TEM 
appears to be a powerful complementary technique to DLS for confirmation of 
the liposomal structure. Unlike DLS, TEM offers the advantage of differentiating 
individual vesicles from aggregates, allowing critical assessment of the liposome 
population. Nevertheless, TEM presents several limitations due to sample prepara-
tion. Apart from being time-consuming, sample pretreatments in TEM analyses 
may cause remarkable changes in liposomal shape or morphology: potential vesicle 
shrinkage, swelling or artifact formation [4, 50].
Parameters Analytical techniques
Particle size Dynamic light scattering (DLS), size exclusion chromatography (SEC), field-flow 
fractionation (FFF) and microscope technology: transmission electron microscopy 
(TEM), cryogenic-TEM (Cryo-TEM), and atomic force microscopy (AFM)
Zeta potential /Surface 
charge
Electrophoretic mobility, DLS
Particle shape /
morphology
Microscopic techniques such as TEM, Cryo-TEM and AFM
Lamellarity Cryo-TEM and 31P-NMR
Phase behavior X-ray diffraction (XRD), differential scanning calorimetry (DSC) and 
thermogravimetric analysis (TGA)
Encapsulation efficiency Centrifugation, dialysis or column separation for liposomes isolation, followed 
by drug content determination
Drug release Dialysis or centrifugation, followed by drug quantification using analytical 
method, such as UV–Vis spectrophotometry, fluorescence spectrometry, 
enzyme- or protein-based assays, gel electrophoresis, HPLC, UPLC, LC-MS
Table 4. 
Analytical methods commonly used for liposomes characterization.
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To overcome these limitations, Cryo-TEM was developed as a strategy to mini-
mize liposome disruption by making use of a flash freezing treatment for direct 
particle visualization in solid-state (without solvent removal). Nowadays, Cryo-
TEM is the most reliable technique for visual determination of liposome structure 
including lamellarity. However, Cryo-TEM appears to be sometimes limited since 
it works perfectly only with very small particles. This has led to the development 
of atomic force microscopy (AFM) for direct particle analysis in native environ-
ments. Although AFM offers the advantage of higher particle resolution at three-
dimensional level, the use of this technique is mostly limited by the high cost of the 
instrument, which compromises its universal availability and accessibility [3, 4].
4.2.3 Differential scanning calorimetry (DSC) and X-ray diffraction (XRD)
DSC and XRD are complementary techniques that evaluate the thermal behavior 
and crystallinity, respectively, and provide valuable information for characteriza-
tion of loaded liposomes [46, 51, 52]. DSC evaluates the differences in heat flow 
(electric power) between a sample and a reference. In DSC experiments, the sample 
and the reference are subjected to a programmed heating, cooling or isothermal 
treatment in a controlled atmosphere (mostly saturated with nitrogen gas). The 
heating treatment is achieved either by the same heater (heat flux DSC) or by sepa-
rate heaters (power compensated DSC). The experiment is conducted in specialized 
metal pans made of aluminum, tin, zinc or indium. Throughout the experiment, 
frequent electric power adjustments occur upon material phase transition (melt-
ing or crystallization), ensuring thermal equilibrium between the sample and the 
reference. This phenomenon is described and expressed by the plot of heat capacity 
against temperature or time (heat flow curve). The heat flow curve provides the 
respective transition temperature and enthalpy, which allows to identify the nature 
of thermal events: endo- or exothermic [53–55]. DSC represents the most useful 
thermal analysis technique in the study of lipid-based materials [46, 52, 54–56].
Unlike DSC where sample recovery is not possible, XRD is a non-destructive ana-
lytical tool that allows structural investigations of crystalline materials. XRD makes 
use of X-rays that deeply penetrate solid materials and provide useful information at 
atomic structure level. Though relatively expensive, an XRD instrument is an envi-
ronmentally and user-friendly device that is easy to use. A wide range of materials 
such as powders, crystals and liquids can be quickly assessed by XRD. Its other advan-
tages include high resolution, reliability, relatively cheap maintenance, and easy data 
collection, processing and interpretation. The phase transitions and polymorphism 
determined by XRD represent valuable information in pharmaceutical development 
and production of both excipients and biologically active materials [57–59].
4.2.4 Lamellarity assays
The lamellarity of liposomes is part of their structural characteristics that can 
have an impact on the intended applications. The number of lipid bilayers can be 
evaluated using chemically labeled or radiolabelled agents that can be distributed 
in the bilayer membranes. However, this technique is limited since these reagents 
might be distributed only on the outer lipid membrane and lead to false readings. 
To date, Cryo-TEM is the most commonly used technique for the determination of 
lamellarity by visualization [4]. The nuclear magnetic resonance spectroscopy of 
the 31-phosphorus (31P-NMR) is also being currently used to estimate the lamel-
larity of liposomes. This technique deals with the estimation of the ratio of phos-
pholipid amount in the outer layers to that of the inner layers [60]. The 31P-NMR 
spectrum with a broad peak indicates the presence of MLV while a narrow peak 
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corresponds to SUV. The addition of paramagnetic ions such as Mn2+, Co2+, and Pr3+ 
shifts the respective peaks to either downfield or upfield because of ionic interac-
tions with the phosphate backbone. By comparing the spectroscopic profile with 
and without the paramagnetic ion, the lamellarity of liposomes can be estimated. 
Some other techniques such as small-angle X-ray scattering (SAXS) and trapped 
volume determination can be used to estimate liposome lamellarity [4, 61].
4.2.5 In vitro release assays
The profile of release for the liposomal cargoes is commonly estimated in vitro 
using dialysis. This method implies trapping the liposomal dispersion into a dialysis 
bag of specific molecular weight cut off. The resultant tubing membrane is placed in 
a simulated physiological fluid (release medium) that is often a buffer maintained 
under well-defined conditions: specific temperature and speed of stirring/shaking. 
At predetermined time intervals, an aliquot is withdrawn from the release medium 
and an equal volume of the fresh buffer is replaced to maintain sink conditions. In 
the withdrawn sample aliquots, the released cargo is quantified using some rou-
tine analytical techniques such as UV-Vis spectrophotometry, HPLC, UPLC, etc., 
adapted to the molecular species under evaluation. The release profile is obtained 
by plotting the cumulative release percentage against the chosen time intervals [4]. 
Data from the in vitro release study are valuably considered as part of the rational 
development of formulations for controlled release, since they allow effective 
prediction of in vivo performance of the delivery systems [62].
5. Applications
Liposomes have evolved so far from mere experimental tools of research to 
industrially established products for clinical and veterinary use. They have shown the 
ability to improve the physicochemical features of the cargoes and ferry them to the 
sites of interest. The concepts of liposomal encapsulation have been applied in several 
fields of life science. Liposomes are frequently used for the delivery of drug, gene, 
vaccine and diagnostic products; but other applications encompass encapsulation of 
food and cosmetic ingredients as well as routine analysis of chemical substances  
[2, 3]. The following paragraphs briefly present the current applications of liposomes.
5.1 Application in drug delivery
The use of liposomes in drug delivery aims at modifying the pharmacokinetics 
of drugs to improve the therapeutic efficacy while minimizing potential toxicity 
[6]. Liposomes can alter the spatial and temporal distribution of the entrapped 
drug molecules in vivo, leading to controlled delivery at the site of interest and 
reduced off-target adverse effects [63]. The liposomal systems have been extensively 
investigated for the delivery of existing and emerging drugs at various research 
levels, from basic stages related to research and development to preclinical and 
clinical applications. Nowadays, liposomes represent the most clinically established 
drug vehicles for human diseases [3, 5]. The efforts invested in liposomal technol-
ogy have so far led to the development of several effective liposomal formulations 
that are currently used in clinics (Table 5).
Liposomal formulations have been used to address a wide range of pathological 
conditions through different administration routes, including dermal, transdermal, 
oral, pulmonary and parenteral routes. The clinical areas commonly explored in 
liposome research encompass skin disorders, cancers and infectious diseases [4]. 
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Amongst, cancer therapy appears to be in the forefront of liposome delivery, due to 
poor bioavailability and side effects of most of the anti-cancer drugs. However, sev-
eral infectious diseases, most specially where the pathogen is hosted by the MNPS 
(i.e., tuberculosis, leishmaniasis, fungal infections), have been reported to be good 
candidates for liposome application, taking advantage of the spontaneous lipo-
somes uptake by the cells of MNPS [2]. Apart from the nature and localization of 
the disease, the design and development of liposomes depend also on the intended 
administration route, since different anatomical and physiological characteristics 
can be encountered from one route to another [46].
Furthermore, the application of liposomes in drug delivery is highly dependent 
on their colloidal and physiochemical features, i.e., vesicle size, surface charge and 
system stability [64]. For instance, small liposomes (SUV) are good candidates for 
Parkinson’s and Alzheimer’s diseases, due to the need for crossing the brain blood 
barrier to achieve brain targeted delivery. Meanwhile, large liposomes are preferred 
for macrophage targeted delivery of antimicrobials, when pathogens are located 
inside the MNPS cells (e.g., tuberculosis, leishmaniasis), taking advantage of the 
passive liposome cell uptake [2, 4, 46]. This underlines the need for thorough explo-
ration of process and formulation parameters at early stages of products develop-
ment to produce liposomes with desired characteristics, making the technology for 
liposomes manufacturing key to future therapeutic research and development.
5.2 Application in gene delivery
Liposomes have been reported to achieve effective intracellular delivery of genes. 
These liposomes, also called lipoplexes, are generally made of cationic lipids, which 
allow for encapsulation of genetic materials via electrostatic interactions with the 
negatively charged phosphate backbones of nucleic acids. The positive charge on 
the surface of liposomes also influences their interactions with negatively charged 
cell membranes and promotes cell internalization [23, 65]. Cationic liposomes offer 
several advantages over viral gene vectors, including easy and safe production, 
Branded 
product
Drug name Therapeutic indications
Abelcet Amphotericin B Fungal infections
AmBisome Amphotericin B Fungal infections
Amphocil Amphotericin B Fungal infections
DaunoXome Daunorubicin Hematological malignancy
DepoCyt Cytarabine Lymphomatous meningitis
DepoDur Morphine sulfate Pain relief
Doxil Doxorubicin Kaposi’s sarcoma and solid tumors
Epaxal Inactivated hepatitis A virus Hepatitis A
Evacet Doxorubicin Ovarian cancer
Inflexal V Inactivated hemagglutinin of influenza virus 
strains A and B
Influenza
LipoDox Doxorubicin Kaposi’s sarcoma and solid tumors
Marqibo Vincristine sulfate Acute lymphoblastic leukemia
Visudyne Verteporfin Photodynamic therapy
Table 5. 
Clinically approved liposomal products [3, 4].
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cost effectiveness, possibility of monitoring toxicity, biodegradability, biocompat-
ibility and lack of dangerous immunogenicity. However, they are suffering from 
poor transfection efficiency due to their limited endosomal escaping ability, which 
exposes the genetic materials to enzymatic and acid degradation in lysosomes. This 
has been improved by incorporating fusogenic lipids, such as DOPE, in the liposomal 
formulation. These helper lipids facilitate endosomal escaping by membrane fusion 
with endosomes, leading to early cytoplasmic release of the gene. Though cationic 
liposomes have shown some dose-dependent toxicity, successful results have been 
obtained in cancer therapy when delivering genes encoding for tumor suppression 
proteins [66, 67]. He et al. have recently developed folate receptor alpha-targeted 
lipoplexes with therapeutic gene expression regulated by an hTERT promoter. These 
liposomes have shown some promise for the treatment of ovarian cancer [68].
5.3 Application in vaccine delivery
The use of specific lipids or molecules such as phosphatidylserine, DOTAP, 
fatty acids and monophosphoryl lipids can produce liposomes with attractive 
immune-stimulating activities. Liposomes carrying antigenic materials, either 
encapsulated in the aqueous core, grafted or coated on the surface; can stimulate 
immune responses on macrophage uptake. Following endolysosomal degradation, 
macrophages present the antigen to T-lymphocytes that initiate the production of 
cytokines and specific antibodies via activation of B-lymphocytes [4]. The immune 
response produced by liposomes can be influenced by their composition, lamel-
larity, size and surface charge [69]. Liposomes containing a glycolipid, trehalose 
6,6'-dibehenate, and a cationic lipid, dimethyldioctadecylammonium, in a 1:5 mass 
ratio have demonstrated efficient delivery of the TB vaccine Ag85B-ESAT-6. This 
vaccine has shown prolonged immune response without any toxic effects [70]. 
Although a liposomal vaccine (namely Stimuvax®) targeting the major histocom-
patibility class I complex for lung carcinoma was not successfully implemented, 
some other vaccines such as Epaxal®, Inflexal® V and Mosquirix® have been 
clinically established for the treatment of hepatitis A, influenza virus infections and 
malaria, respectively. These vaccines, classified as virosomes, are liposomes gener-
ally made of reconstituted viral envelop supplemented with phosphatidylcholine. 
They offer the advantage of undergoing membrane fusion either with the cells or 
the endosomes, and thus leading to efficient cytosolic delivery [2, 9].
5.4 Application in diagnosis
The use of liposomes for diagnostic purposes is one of current topics of great 
interest in biomedical applications. Liposomes with magnetic properties, also 
called magnetoliposomes, are made by entrapping superparamagnetic iron-based 
nanoparticles or iron oxides or gadolinium (III) chelates for magnetic resonance 
imaging. Functionalized liposomes labeled with radioisotopes can also be used as 
molecular probes in nuclear imaging. For instance, liposomes labeled with 64Cu, 18F, 
89Zr or 52Mn have been reported in positron emission tomography while 99mTC, 111In 
or 67Ga labeled liposomes were applied in single photon emission computed tomog-
raphy. Acoustic liposomes which are liposomes made of perfluoropropane gas can 
be used as contrast agents in ultrasound imaging technique. The encapsulation of 
quantum dots and fluorescent dyes into liposomes has also led to the development 
of attractive liposomal platforms for diagnosis. Additionally, liposomes have shown 
great potential for simultaneous accommodation of drugs and diagnostic agents 
such as radionuclides, magnetic or contrast substances. This can be achieved by 
encapsulation in the inner core, embedding in the lipid bilayer, chemically grafting 
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or coating onto the surface of liposomes. A successful targeted co-delivery of these 
materials has given to liposomes the status of theranostic systems, as they provide 
both the therapeutic effect and the diagnostic control [2, 71, 72].
5.5 Application in analytical fields
In analytical domains, liposome-based formulations can be usefully involved in 
immunoassays, biosensors analysis and liquid chromatography. Liposomes can be 
used to encapsulate, embed or conjugate the analytical entities with high loading 
capacity and huge surface area that can enhance the intensity of analytical signal. In 
a direct enzyme-linked immunosorbent assay (ELISA) like method, fluorophore-
conjugated liposomes carrying a substantial amount of secondary antibody quickly 
bind to the antigen that has been fixed on the primary antibody. The addition 
of a colorimetric substrate leads to color development and allows for analytical 
estimation of the antigenic analyte. The use of liposomes has been deemed to lower 
the limits of detection of analytes and increase the sensitivity of immunological 
analysis technique [73]. In chromatography, the conjugation of liposomes to the 
stationary phase for gel permeation chromatography is useful for separation of 
drugs and proteins and for exploring possible molecular interactions on phospho-
lipid membranes. Additionally, the cell-like appearance of liposomes makes them 
appropriate simulated cell models for studying and predicting the interactions 
between biologically active compounds and cell membranes [4].
5.6 Application in cosmetics
The use of liposomes in the field of cosmetics is based on the similarity between 
the lipid composition of the liposomal vesicle and that of the biological layers com-
posing the skin. Because phospholipids can be subject to hydration, topical liposomes 
happen to contribute to the reduction of skin dryness. While playing the role of 
attractive vehicles for relevant cosmetic agents, liposomes provide a great source of 
skin ingredients, such as essential unsaturated fatty acids like linolenic acid. This has 
shown great potential for maintaining the skin and hair in good physiological stand-
ing, preventing the rise of some common topical diseases. Furthermore, the use of 
skin care formulations made of empty or hydrating agents loaded liposomes helps to 
reduce the transdermal water loss, which is a major cause of skin dryness [74, 75].
5.7 Application in food industry
As versatile lipid-based systems, liposomes have shown some potential in the 
encapsulation of food ingredients. In this field, the use of liposomes aims to stabilize 
some nutraceutical or dietetic ingredients during the storage, to improve their organo-
leptic characters or to provide a controlled and targeted delivery of these substances 
in a specific tissue. The shelf life and efficacy of instable bioactive products such as 
vitamins, enzymes and anti-oxidative agents have been prolonged by their liposomal 
encapsulation. For example, proteinase and lipase loaded liposomes have been reported 
to improve the ripening of cheese notably in preventing proteolysis of casein [28, 76]. 
Yokota et al. [27] have successfully improved the taste and odor of casein hydrolysate 
in dietetic preparations by liposomal encapsulation. In addition to the encapsulation 
of dietetic compounds, liposomes have been recently used to encapsulate a cyanobac-
terium, namely Spirulina platensis, as a source of proteins [77]. Although the use of 
liposomes in food industry is still at the infant stages of development, advanced studies 
have been launched to investigate much more attractive applications, such as detection 
of food contaminants by means of stimuli-responsive liposomes for food safety [76].
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6. Conclusion
Liposomes appear to be reputed carriers for various chemical and macromolecu-
lar species. From way back their discovery, liposomes have been subject to extensive 
evolution, in terms of composition, manufacturing and usages, which led to several 
openings in both basic and applied life sciences. The general details presented 
herein attempted to reveal some of the existing gaps in liposomes technology and 
open new windows for further research. An important future breakthrough could 
be the discovery of cost-effective materials to formulate liposome vesicles with 
remarkable versatility viz., being suitable as vehicles for various molecules while 
holding a clear molecular architecture to act as cell models for in vitro bioassays. 
In addition, novel manufacturing methods for facile encapsulation of both hydro-
phobic and hydrophilic molecules with no need for organic solvents and special 
equipment or sophisticated infrastructures are highly desired. Furthermore, the 
critical issue of system instability for liposomes loaded with hydrophilic materials 
requires new strategies that will achieve acceptable loading while aiming at target-
ing cargo delivery at the site of interest. Finally, since liposomes have demonstrated 
some clinical success as drug vehicles, future efforts should be dedicated to ensur-
ing wider developments and implementation of therapeutic liposomes. This would 
enhance commercial availability and accessibility of liposome products across the 
globe, particularly in low- and middle-income countries.
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